In 2022, the global Anti-Obesity Therapeutics Market reached a size of USD 4.95 billion, and it is anticipated to attain USD 7.68 billion by 2032, experiencing a compound annual growth rate (CAGR) of 5% throughout the forecast period. The primary driver for the escalating revenue in the market is the increasing prevalence of obesity worldwide. The World Health Organization (WHO) has reported a...